SERO-PREVALENCE OF ANTI- TOXOPLASMA GONDII ANTIBODIES AMONG PATIENTS WITH NEUROPSYCHIATRIC DISORDERS: EPILEPSY AND DEPRESSION

Investigation of the possible relation between seropositivity to anti-Toxoplasma immunoglobulin-G, peripheral dopamine, cortisol, and oxidative stress in Egyptian schizophrenic p

TOXOPLASMOSIS AMONG SCHIZOPHRENIC PATIENTS

SEROPREVALENCE OF TOXOPLASMA GONDII INFECTION AND ITS ASSOCIATED RISK FACTORS IN NEUROPSYCHIATRIC PATIENTS IN JAZAN PROVINCE, SAUDI ARABIA

Insights into the interplay of latent toxoplasmosis, testosterone, cortisol and oxidative stress in screened schizophrenic patients in Egypt

THE EFFECTS OF TWO ANTIPSYCHOTIC DRUGS AND PROLACTIN ON TOXOPLASMA GONDII TACHYZOITES IN VIVO

TOXOPLASMOSIS AND RISK OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER AND MAJOR DEPRESSIVE DISORDER: A REVIEW ARTICLE

Investigation of the relationship between schizophrenia and toxoplasmosis in Van province, Turkey

TOXOPLASMA GONDII SEROPOSITIVITY IN RENAL PATIENTS: RATE, PATTERN, PREDICTORS AND RELATED MORBIDITY

SEROPREVALENCE OF TOXOPLASMA GONDII INFECTION AND ASSOCIATED RISK FACTORS AMONG ASYMPTOMATIC PREGNANT FEMALES IN EGYPT